title: OCT-1 as a determinant of response to antileukemic treatment.
authors.affiliation: Department of Haematology, SA Pathology (RAH Campus), Adelaide, Australia.
authors.forename: J R
authors.initials: JR
authors.lastname: Engler
authors.forename: T P
authors.initials: TP
authors.lastname: Hughes
authors.forename: D L
authors.initials: DL
authors.lastname: White
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D001549:Benzamides; D019008:Drug Resistance, Neoplasm; D006801:Humans; D000068877:Imatinib Mesylate; D015466:Leukemia, Myeloid, Chronic-Phase / Q000188:drug therapy* / Q000473:pathology; D027702:Organic Cation Transporter 1 / Q000378:metabolism*; D010879:Piperazines / Q000494:pharmacology*; D047428:Protein Kinase Inhibitors / Q000494:pharmacology*; D011743:Pyrimidines / Q000494:pharmacology*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D027702:Organic Cation Transporter 1; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate